Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors

First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors
Condition:   Advanced Solid Tumor
Intervention:   Drug: STP1002
Sponsors:   ST Pharm Co., Ltd.;   KCRN Research, LLC
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 11, 2020 / by / in
Comments